General Information of Drug Off-Target (DOT) (ID: OT9D9T2F)

DOT Name Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial (PDHA2)
Synonyms EC 1.2.4.1; PDHE1-A type II
Gene Name PDHA2
Related Disease
Estrogen-receptor positive breast cancer ( )
Male infertility ( )
Pyruvate dehydrogenase complex deficiency ( )
Spermatogenic failure 70 ( )
UniProt ID
ODPAT_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
1.2.4.1
Pfam ID
PF00676
Sequence
MLAAFISRVLRRVAQKSARRVLVASRNSSNDATFEIKKCDLYLLEEGPPVTTVLTRAEGL
KYYRMMLTVRRMELKADQLYKQKFIRGFCHLCDGQEACCVGLEAGINPSDHVITSYRAHG
VCYTRGLSVRSILAELTGRRGGCAKGKGGSMHMYTKNFYGGNGIVGAQGPLGAGIALACK
YKGNDEICLTLYGDGAANQGQIAEAFNMAALWKLPCVFICENNLYGMGTSTERAAASPDY
YKRGNFIPGLKVDGMDVLCVREATKFAANYCRSGKGPILMELQTYRYHGHSMSDPGVSYR
TREEIQEVRSKRDPIIILQDRMVNSKLATVEELKEIGAEVRKEIDDAAQFATTDPEPHLE
ELGHHIYSSDSSFEVRGANPWIKFKSVS
Function The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle.
Tissue Specificity Testis. Expressed in postmeiotic spermatogenic cells.
KEGG Pathway
Glycolysis / Gluconeogenesis (hsa00010 )
Citrate cycle (TCA cycle) (hsa00020 )
Pyruvate metabolism (hsa00620 )
Lipoic acid metabolism (hsa00785 )
Metabolic pathways (hsa01100 )
Carbon metabolism (hsa01200 )
2-Oxocarboxylic acid metabolism (hsa01210 )
HIF-1 sig.ling pathway (hsa04066 )
Glucagon sig.ling pathway (hsa04922 )
Central carbon metabolism in cancer (hsa05230 )
Diabetic cardiomyopathy (hsa05415 )
Reactome Pathway
Glyoxylate metabolism and glycine degradation (R-HSA-389661 )
Signaling by Retinoic Acid (R-HSA-5362517 )
Pyruvate metabolism (R-HSA-70268 )
Regulation of pyruvate dehydrogenase (PDH) complex (R-HSA-204174 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Estrogen-receptor positive breast cancer DIS1H502 Strong Biomarker [1]
Male infertility DISY3YZZ Strong Biomarker [2]
Pyruvate dehydrogenase complex deficiency DIS8RZP9 Strong Genetic Variation [3]
Spermatogenic failure 70 DIS3CUS6 Limited Unknown [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Permethrin DMZ0Q1G Approved Permethrin increases the expression of Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial (PDHA2). [4]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial (PDHA2). [5]
------------------------------------------------------------------------------------

References

1 Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical-only ER-positive breast cancer.J Cell Physiol. 2019 Jul;234(7):11140-11148. doi: 10.1002/jcp.27756. Epub 2018 Dec 7.
2 Linked homozygous BMPR1B and PDHA2 variants in a consanguineous family with complex digit malformation and male infertility. Eur J Hum Genet. 2018 Jun;26(6):876-885. doi: 10.1038/s41431-018-0121-7. Epub 2018 Mar 26.
3 Complex genetic findings in a female patient with pyruvate dehydrogenase complex deficiency: Null mutations in the PDHX gene associated with unusual expression of the testis-specific PDHA2 gene in her somatic cells.Gene. 2016 Oct 15;591(2):417-24. doi: 10.1016/j.gene.2016.06.041. Epub 2016 Jun 22.
4 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.